(Q48173387)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

Wayne L Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Karen A Hartman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mary F Burritt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

John C Burnett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Allan S Jaffe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

245-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

Preload induces troponin I degradation independently of myocardial ischemia

30 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCLC.20075

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

21 January 2018

1 reference

12 December 2020

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

12 December 2020

Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes

1 reference

12 December 2020

Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction

1 reference

12 December 2020

Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.

1 reference

12 December 2020

Plasma brain natriuretic peptide concentration: impact of age and gender

1 reference

12 December 2020

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

12 December 2020

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

1 reference

12 December 2020

Prognostic use of cardiac troponin T and troponin I in patients with heart failure

1 reference

12 December 2020

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure

1 reference

12 December 2020

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.

1 reference

12 December 2020

Impact of obesity on plasma natriuretic peptide levels

1 reference

12 December 2020

High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure.

1 reference

12 December 2020

Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis

1 reference

12 December 2020

Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data

1 reference

12 December 2020

Biochemical markers of myocyte injury in heart failure

1 reference

12 December 2020

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

1 reference

12 December 2020

Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification

1 reference

12 December 2020

Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction

1 reference

12 December 2020

Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients

1 reference

12 December 2020

Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure

1 reference

12 December 2020

Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications

1 reference

12 December 2020

The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease

1 reference

12 December 2020

Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both

1 reference

12 December 2020

Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide

1 reference

12 December 2020

Reliability of ventricular remodeling as a surrogate for use in conjunction with clinical outcomes in heart failure

1 reference

12 December 2020

Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.

1 reference

12 December 2020

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

1 reference

12 December 2020

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

1 reference

12 December 2020

Apoptosis in myocytes in end-stage heart failure

1 reference

12 December 2020

Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.20075

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

17492679

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17492679%20AND%20SRC:MED&resulttype=core&format=json